Literature DB >> 25375900

Identification of verocytotoxin-producing Escherichia coli O117:H7 in men who have sex with men, England, November 2013 to August 2014.

I Simms1, V L Gilbart, L Byrne, C Jenkins, G K Adak, G Hughes, P D Crook.   

Abstract

Between November 2013 and August 2014, nine cases of verocytotoxin-producing Escherichia coli O117:H7 VT1 were confirmed in adult men. Further investigation using semi-structured interviews revealed that eight cases were United Kingdom (UK)-born men who have sex with men (MSM) who had sexually acquired infection in the UK. Most were HIV-positive with high numbers of sexual partners. This behavioural profile resembles that associated with the recent rapid increase in other sexually acquired infections in MSM.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25375900     DOI： 10.2807/1560-7917.es2014.19.43.20946

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  10 in total

1.  Assessing the public health risk of Shiga toxin-producing Escherichia coli by use of a rapid diagnostic screening algorithm.

Authors:  Richard F de Boer; Mithila Ferdous; Alewijn Ott; Henk R Scheper; Guido J Wisselink; Max E Heck; John W Rossen; Anna M D Kooistra-Smid
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

2.  Safer chemsex: consideration of Shigella.

Authors:  Manpreet Bains; Paul Crook; Nigel Field; Gwenda Hughes
Journal:  Br J Gen Pract       Date:  2016-03       Impact factor: 5.386

3.  Brazilian Protocol for Sexually Transmitted Infections, 2020: sexually transmitted enteric infections.

Authors:  Edilbert Pelegrini Nahn Junior; Eduardo Campos de Oliveira; Marcelo Joaquim Barbosa; Thereza Cristina de Souza Mareco; Helena Andrade Brígido
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

4.  Use of gender distribution in routine surveillance data to detect potential transmission of gastrointestinal infections among men who have sex with men in England.

Authors:  P Mook; D Gardiner; S Kanagarajah; M Kerac; G Hughes; N Field; N McCarthy; C Rawlings; I Simms; C Lane; P D Crook
Journal:  Epidemiol Infect       Date:  2018-06-20       Impact factor: 4.434

5.  Neuroinvasive Infection from O117:K52:H-Escherichia coli following Acute Pyelonephritis.

Authors:  H Cromlin; H Rodriguez-Villalobos; A Deplano; T Duprez; P Hantson
Journal:  Case Rep Infect Dis       Date:  2017-11-26

6.  Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species.

Authors:  Kate S Baker; Timothy J Dallman; Nigel Field; Tristan Childs; Holly Mitchell; Martin Day; François-Xavier Weill; Sophie Lefèvre; Mathieu Tourdjman; Gwenda Hughes; Claire Jenkins; Nicholas Thomson
Journal:  Nat Commun       Date:  2018-04-13       Impact factor: 14.919

7.  An outbreak of a rare Shiga-toxin-producing Escherichia coli serotype (O117:H7) among men who have sex with men.

Authors:  Kate S Baker; Timothy J Dallman; Nicholas R Thomson; Claire Jenkins
Journal:  Microb Genom       Date:  2018-05-21

8.  Elevated prevalence of multidrug-resistant gram-negative organisms in HIV positive men.

Authors:  Claudia Reinheimer; Oliver T Keppler; Christoph Stephan; Thomas A Wichelhaus; Imke Friedrichs; Volkhard A J Kempf
Journal:  BMC Infect Dis       Date:  2017-03-13       Impact factor: 3.090

9.  Risk Factors for Asymptomatic Enteric Pathogen Detection Among Men Who Have Sex With Men.

Authors:  Deborah A Williamson; Eric P F Chow; Darren Lee; Kate Maddaford; Michelle Sait; Marion Easton; Danielle Ingle; Rebecca Wigan; Vesna De Petra; Benjamin P Howden; Christopher K Fairley; Marcus Y Chen
Journal:  Open Forum Infect Dis       Date:  2019-07-11       Impact factor: 3.835

10.  Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012-2015.

Authors:  Dana Eikmeier; Pamela Talley; Anna Bowen; Fe Leano; Ginette Dobbins; Selina Jawahir; Annastasia Gross; Dawn Huspeni; Allison La Pointe; Stephanie Meyer; Kirk Smith
Journal:  Emerg Infect Dis       Date:  2020-04       Impact factor: 6.883
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.